🔗 Visit the ClinicalTrials.gov page for NCT01303341
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Glutamate signaling in benign and malignant disorders: current status, future perspectives, and therapeutic implications. | Int J Biol Sci | 2013 | 0.96 |
| 2 | Altered glutamine metabolism and therapeutic opportunities for lung cancer. | Clin Lung Cancer | 2013 | 0.93 |
| 3 | Advances in personalized targeted treatment of metastatic melanoma and non-invasive tumor monitoring. | Front Oncol | 2013 | 0.89 |
| 4 | Metastatic melanoma - a review of current and future drugs. | Drugs Context | 2012 | 0.83 |
| 5 | Upfront molecular testing in patients with advanced gastro-esophageal cancer: Is it time yet? | Oncotarget | 2015 | 0.76 |